European Society for Medical Oncology (ESMO), shared a post on LinkedIn:
“Do all patients in Europe have equal access to cancer clinical trials?
New ESMO report covering 34 countries highlights important disparities in where trials take place and who can access them.
These findings provide new evidence to inform EU discussions on equitable access to clinical trials.
Read the report here
Findings presented to EU policymakers in Brussels.”
Other articles about ESMO on OncoDaily.
